| 3/21/2024 | 30049049 | New medicine: ROCURONIUM KABI 10 MG/ML (Rocuronium bromide 10mg/ml). solution for injection or intravenous infusion. Box of 10 vials x 5ml. LOT: 16SM14. Manufacturer: December 20, 2023. NHH: December 20, 2026. VN-22745-21. | XXXXXXXXXX | 6384 | UNK | 159928.1376 | Austria | NA |
| 3/14/2024 | 30049049 | New medicine: ROCURONIUM KABI 10 MG/ML (Rocuronium bromide 10mg/ml). solution for injection or intravenous infusion. Box of 10 vials x 5ml. LOT: 16SE18. Production: May 30, 2023. NHH: May 30, 2026. VN-22745-21. | XXXXXXXXXX | 5124 | UNK | 127823.8164 | Austria | NA |
| 1/30/2024 | 30049049 | VELCADE medicine (Bortezomib 1mg). Box of 1 vial. Powder for intravenous injection. Batch: NGZSP01. Production: July 2023. Expiry date: July 2026. Registration number:VN2-327-15. New 100%. | XXXXXXXXXX | 4256 | Box/Bag/Pack | 503515.06016 | Italy | NA |
| 1/23/2024 | 30049049 | New medicine: ROCURONIUM KABI 10 MG/ML (Rocuronium bromide 10mg/ml). solution for injection or intravenous infusion. Box of 10 vials x 5ml. LOT: 16SE18. Production: May 30, 2023. NHH: May 30, 2026. VN-22745-21. | XXXXXXXXXX | 8400 | Box/Bag/Pack | 209593.356 | Austria | NA |
| 1/17/2024 | 30049049 | Anifrolumab (MEDI-546) 150mg/mL/Placebo, concentrated solution for mixing intravenous infusion solution, 1 box includes 1 vial of 2ml. Lot number 30424.11/1. Deadline June 30, 2025. Manufacturer AstraZeneca Nijmegen BV 100% new product | XXXXXXXXXX | 15 | Box/Bag/Pack | 1641.88635 | Netherland | NA |
| 1/17/2024 | 30049049 | Anifrolumab (MEDI-546) 150mg/mL/Placebo, concentrated solution for mixing intravenous infusion solution, 1 box includes 1 vial of 2ml. Lot number 30424.11/1. Deadline June 30, 2025. Manufacturer AstraZeneca Nijmegen BV 100% new product | XXXXXXXXXX | 45 | Box/Bag/Pack | 4925.65905 | Netherland | NA |
| 1/16/2024 | 30049049 | Anifrolumab (MEDI-546) 150mg/mL/Placebo, concentrated solution for mixing intravenous infusion solution, 1 box includes 1 vial of 2ml. Lot number 30424.11/1. Deadline June 30, 2025. Manufacturer AstraZeneca Nijmegen BV 100% new product | XXXXXXXXXX | 34 | Box/Bag/Pack | 3721.60906 | Netherland | NA |
| 1/16/2024 | 30049049 | Anifrolumab (MEDI-546) 150mg/mL/Placebo, concentrated solution for mixing intravenous infusion solution, 1 box includes 1 vial of 2ml. Lot number 30424.11/1. Deadline June 30, 2025. Manufacturer AstraZeneca Nijmegen BV 100% new product | XXXXXXXXXX | 18 | Box/Bag/Pack | 1970.26362 | Netherland | NA |
| 1/16/2024 | 30049049 | Anifrolumab (MEDI-546) 150mg/mL/Placebo, concentrated solution for mixing intravenous infusion solution, 1 box includes 1 vial of 2ml. Lot number 30424.11/1. Deadline June 30, 2025. Manufacturer AstraZeneca Nijmegen BV 100% new product | XXXXXXXXXX | 38 | Box/Bag/Pack | 4159.44542 | Netherland | NA |
| 1/16/2024 | 30049049 | Anifrolumab (MEDI-546) 150mg/mL/Placebo, concentrated solution for mixing intravenous infusion solution, 1 box includes 1 vial of 2ml. Lot number 30424.6/1. Deadline August 31, 2024. Manufacturer AstraZeneca Nijmegen BV 100% new product | XXXXXXXXXX | 48 | Box/Bag/Pack | 5254.03632 | Netherland | NA |